-
1
-
-
0022970945
-
Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
-
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
-
(1986)
Circulation
, vol.74
, pp. 1124-1136
-
-
Murry, C.E.1
Jennings, R.B.2
Reimer, K.A.3
-
2
-
-
0028182641
-
ATP channels in ischaemic preconditioning
-
ATP channels in ischaemic preconditioning. Cardiovasc Res 1994;28:783-787.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 783-787
-
-
Parratt, J.R.1
Kane, K.A.2
-
3
-
-
0026490398
-
Ischemic preconditioning protects against infarction in the rat heart
-
Liu GS, Downey JM. Ischemic preconditioning protects against infarction in the rat heart. Am J Physiol 1992;263:H1107-12.
-
(1992)
Am J Physiol
, vol.263
-
-
Liu, G.S.1
Downey, J.M.2
-
4
-
-
0025999672
-
Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits
-
Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84:341-9.
-
(1991)
Circulation
, vol.84
, pp. 341-349
-
-
Cohen, M.V.1
Liu, G.S.2
Downey, J.M.3
-
5
-
-
85047677669
-
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
-
Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 1992;26:1054-62.
-
(1992)
Cardiovasc Res
, vol.26
, pp. 1054-1062
-
-
Auchampach, J.A.1
Grover, G.J.2
Gross, G.J.3
-
6
-
-
0025219050
-
Ischemic preconditioning reduces infarct size in swine myocardium
-
Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-42.
-
(1990)
Circ Res
, vol.66
, pp. 1133-1142
-
-
Schott, R.J.1
Rohmann, S.2
Braun, E.R.3
Schaper, W.4
-
7
-
-
0026547286
-
Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
-
Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
-
(1992)
Circ Res
, vol.70
, pp. 223-233
-
-
Gross, G.J.1
Auchampach, J.A.2
-
8
-
-
85047678046
-
Preconditioning: State of the art myocardial protection
-
Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993;27:542-550.
-
(1993)
Cardiovasc Res
, vol.27
, pp. 542-550
-
-
Lawson, C.S.1
Downey, J.M.2
-
9
-
-
0027240733
-
Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts
-
Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993;72:44-9.
-
(1993)
Circ Res
, vol.72
, pp. 44-49
-
-
Thornton, J.D.1
Thornton, C.S.2
Sterling, D.L.3
Downey, J.M.4
-
10
-
-
0027285011
-
Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide
-
Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993;27:617-22.
-
(1993)
Cardiovasc Res
, vol.27
, pp. 617-622
-
-
Toombs, C.F.1
Moore, T.L.2
Shebuski, R.J.3
-
12
-
-
0028909798
-
Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anaesthetized with xylazine/pentobarbital but not with pentobarbital alone
-
Miura T, Goto M, Miki T, Sakamoto J, Shimamoto K, Iimura O. Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anaesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol 1995;25:531-8.
-
(1995)
J Cardiovasc Pharmacol
, vol.25
, pp. 531-538
-
-
Miura, T.1
Goto, M.2
Miki, T.3
Sakamoto, J.4
Shimamoto, K.5
Iimura, O.6
-
15
-
-
0024339582
-
Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion
-
Thiemermann C, Thomas RG, Vane JR. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol 1989;97:401-8.
-
(1989)
Br J Pharmacol
, vol.97
, pp. 401-408
-
-
Thiemermann, C.1
Thomas, R.G.2
Vane, J.R.3
-
16
-
-
0028429949
-
A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion
-
A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br. J Pharmacol 1994;112:75-80.
-
(1994)
Br. J Pharmacol
, vol.112
, pp. 75-80
-
-
McMurdo, L.1
Thiemermann, C.2
Vane, J.R.3
-
17
-
-
33749913679
-
Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction
-
Maxwell MP, Hearse DJ, Yellon DJ. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46.
-
(1987)
Cardiovasc Res
, vol.21
, pp. 737-746
-
-
Maxwell, M.P.1
Hearse, D.J.2
Yellon, D.J.3
-
18
-
-
0019508591
-
A critical look at currently used indices of myocardial oxygen consumption
-
Baller D, Bretschneider HJ, Hellige G. A critical look at currently used indices of myocardial oxygen consumption. Basic Res Cardiol 1981;76:163-81.
-
(1981)
Basic Res Cardiol
, vol.76
, pp. 163-181
-
-
Baller, D.1
Bretschneider, H.J.2
Hellige, G.3
-
19
-
-
0001120360
-
Macroscopic identification of early myocardial infarct by alterations in dehydrogenase activity
-
Nachlas MM, Shnitka TK. Macroscopic identification of early myocardial infarct by alterations in dehydrogenase activity. Am J Pathol 1963;43:379-405.
-
(1963)
Am J Pathol
, vol.43
, pp. 379-405
-
-
Nachlas, M.M.1
Shnitka, T.K.2
-
20
-
-
0026048387
-
Specific block of the anti-ischaemic actions of cromakalim by sodium 5-hydroxydecanoate
-
McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischaemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 1991;69:949-58.
-
(1991)
Circ Res
, vol.69
, pp. 949-958
-
-
McCullough, J.R.1
Normandin, D.E.2
Conder, M.L.3
Sleph, P.G.4
Dzwonczyk, S.5
Grover, G.J.6
-
23
-
-
0028876411
-
Endothelin-1 reduces myocardial infarct size by activating ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion
-
Hide EJ, Piper J, Thiemermann C. Endothelin-1 reduces myocardial infarct size by activating ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br. J. Pharmacol. 1995;116:2597-2602.
-
(1995)
Br. J. Pharmacol.
, vol.116
, pp. 2597-2602
-
-
Hide, E.J.1
Piper, J.2
Thiemermann, C.3
-
26
-
-
0025696538
-
The pharmacologic profile of cromakalim in the treatment of myocardial ischaemia in isolated rat hearts and anaesthetised dogs
-
Grover GJ, Sleph PG, Dzwonczyk S. The pharmacologic profile of cromakalim in the treatment of myocardial ischaemia in isolated rat hearts and anaesthetised dogs. J Cardiovasc Res 1990;16:853-64.
-
(1990)
J Cardiovasc Res
, vol.16
, pp. 853-864
-
-
Grover, G.J.1
Sleph, P.G.2
Dzwonczyk, S.3
-
27
-
-
0028968801
-
Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat
-
Wu CC, Thiemermann C, Vane JR. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol 1995;114:1273-81.
-
(1995)
Br J Pharmacol
, vol.114
, pp. 1273-1281
-
-
Wu, C.C.1
Thiemermann, C.2
Vane, J.R.3
-
28
-
-
0024460927
-
Anti-ischaemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with these effects with the potassium channel blocker glyburide
-
Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischaemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-104.
-
(1989)
J Pharmacol Exp Ther
, vol.251
, pp. 98-104
-
-
Grover, G.J.1
McCullough, J.R.2
Henry, D.E.3
Conder, M.L.4
Sleph, P.G.5
-
29
-
-
85047675694
-
Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning
-
Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 1994;28:1574-80.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 1574-1580
-
-
Haessler, R.1
Kuzume, K.2
Chien, G.L.3
Wolff, R.A.4
Davis, R.F.5
Van Winkle, D.M.6
-
31
-
-
0024460927
-
The anti-ischaemic effects of the potassium channnel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide
-
Grover GJ, McCullough JR, Henry DE, Condor ML, Sleph PG. The anti-ischaemic effects of the potassium channnel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-110.
-
(1989)
J Pharmacol Exp Ther
, vol.251
, pp. 98-110
-
-
Grover, G.J.1
McCullough, J.R.2
Henry, D.E.3
Condor, M.L.4
Sleph, P.G.5
|